Back
77
Also listed as
AAVXF
OTC
Day Range
$115.02
$122.97
52-Week Range
$4.77
$148.83
Volume
1,265,517
50D / 200D Avg
$119.11
/
$87.46
Prev Close
$120.34
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -42.9 | 0.4 |
| P/B | 186.5 | 2.9 |
| ROE % | -149.0 | 3.7 |
| Net Margin % | -1633.1 | 3.9 |
| Rev Growth 5Y % | 261.8 | 10.0 |
| D/E | 2.4 | 0.2 |
Analyst Price Target
Hold
$142.50
+23.5%
Low: $110.00
High: $176.00
Forward EPS
-$3.07
Est. Revenue
3.8 M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$4.96
$3.05 – $6.87
|
1.5 B | 1 |
| FY2029 |
$5.35
$3.29 – $7.41
|
1.2 B | 1 |
| FY2028 |
$0.71
$0.31 – $1.11
|
570 M | 2 |
Key Takeaways
Revenue grew 261.78% annually over 5 years — strong growth
Debt/Equity of 2.40 — high leverage
Negative free cash flow of -154.72M
PEG of 0.14 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 128.24%
Capital efficient — spends only 5.96% of revenue on capex
Growth
Revenue Growth (5Y)
261.78%
Revenue (1Y)133.54%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-148.98%
ROIC-94.05%
Net Margin-1633.08%
Op. Margin-1602.89%
Safety
Debt / Equity
2.40
Current Ratio1.84
Interest Coverage-41.33
Valuation
P/E Ratio
-42.94
P/B Ratio186.47
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 133.54% | Revenue Growth (3Y) | 53.45% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 261.78% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 10.79M | Net Income (TTM) | -176.24M |
| ROE | -148.98% | ROA | -85.88% |
| Gross Margin | 100.00% | Operating Margin | -1602.89% |
| Net Margin | -1633.08% | Free Cash Flow (TTM) | -154.72M |
| ROIC | -94.05% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 2.40 | Current Ratio | 1.84 |
| Interest Coverage | -41.33 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -42.94 | P/B Ratio | 186.47 |
| P/S Ratio | 701.25 | PEG Ratio | 0.14 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 7.57B | Enterprise Value | 7.52B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 10.79M | 4.62M | 4.58M | 37,000.0 | 63,000.0 |
| Net Income | -176.24M | -147.74M | -60.74M | -42.45M | -37.55M |
| EPS (Diluted) | -2.80 | -3.43 | -3.18 | -2.75 | -2.62 |
| Gross Profit | 10.79M | 4.57M | 4.47M | -119,000.0 | -33.77M |
| Operating Income | -172.98M | -127.38M | -64.84M | -41.40M | -38.01M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 205.23M | 327.06M | 75.54M | 109.23M | 71.30M |
| Total Liabilities | 164.64M | 131.05M | 68.36M | 83.30M | 53.40M |
| Shareholders' Equity | 40.58M | 196.01M | 7.19M | 25.93M | 17.90M |
| Total Debt | 97.36M | 58.04M | 39.16M | 51.65M | 33.99M |
| Cash & Equivalents | 144.22M | 251.94M | 26.95M | 60.70M | 29.30M |
| Current Assets | 170.67M | 285.97M | 36.18M | 75.21M | 37.67M |
| Current Liabilities | 92.83M | 88.12M | 51.46M | 32.26M | 19.41M |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Full Throttle
#5 of 146
Recent Activity
Entered
Full Throttle
Mar 24, 2026